Savient Pharmaceuticals Earnings: Everything You Must Know Now

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.

Savient Pharmaceuticals, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased to $-0.35 in the quarter versus EPS of $-0.23 in the year-earlier quarter.

Revenue: Rose 31.75% to $6.1 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Savient Pharmaceuticals, Inc. reported adjusted EPS loss of $0.35 per share. By that measure, the company missed the mean analyst estimate of $-0.31. It beat the average revenue estimate of $5.84 million.

Key Stats (on next page)…

Revenue increased 30.06% from $4.69 million in the previous quarter. EPS decreased to $-0.35 in the quarter versus EPS of $-0.34 in the previous quarter.

Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.26 to a loss $0.28. For the current year, the average estimate has moved down from a loss of $1.10 to a loss of $1.21 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]